Search
Searching Content indexed under Litigation, Mediation & Arbitration by Jennifer Roscetti ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Dead Zone: Are Your Biological Products Ready For FDA's Regulatory Transition?
On March 23, 2020, hundreds of approved and pending applications for biological products will face a regulatory transition as the U.S. Food and Drug Administration (FDA) implements...
United States
6 Jun 2017
2
Dead Zone: Are Your Biological Products Ready For FDA's Regulatory Transition?
On that date, FDA will replace all approved new drug applications (NDAs) and abbreviated new drug applications (ANDAs) for biologics with biologic license applications (BLAs) or abbreviated...
United States
1 Jun 2017
3
Infringement Under Section 271(F)(1): More Than One Piece Of The Puzzle Required
In patent cases where the accused infringer supplies some or all of the component parts of an accused product from the United States to an overseas location for final assembly...
United States
15 May 2017
Links to Result pages
 
1